Pathogenus Consulting Ltd. arose from former iterations (CHIMagents Ltd. and CHIMunomics) and was created to offer a wider range of clinical trial and other life sciences services than was possible with the original focus on human challenge agents and trials. Building out from specialist clinical studies to full pre-clinical to late-phase and expanding the talent pool by employing former industry leaders and executives, the new company builds on over a decade of industry and academic consultancy as well as a broad range of successful projects, helping clients to achieve positive outcomes for their endpoints for a variety of drug, vaccine and medical device trials. With a focus on infectious diseases, the team offers on-tap specialists in project management, operational and change management, scientific and clinical guidance and analyses, project and protocol design and medical writing. Together we have grown to form an international consultancy with experience in most ID pathologies and global regulatory jurisdictions. PCL can help develop drug and vaccine candidates from R&D to market authorisation, avoiding or mitigating for problems and pitfalls along the way. Call or email and see how we can derisk your journey to exit or raise additional capital from positive outcomes.